 | The role of post-translationally modified antigen in rheumatoid arthritis (NHMRC Project Grant administered by The University of Melbourne), 2008 - 2010
Funded by: University of Melbourne |
| Phase 1 trial of autologous dendritic cells to induce antigen specific tolerance in patients with rheumatoid arthritis: equipment required for cell purification, 2008 - 2008
Funded by: PA Foundation |
| Genetic and Genomic Analysis Research Facility, 2007 - 2007
Funded by: RL Cooper Medical Research Foundation Limited |
| Research Donation - Ms Lesleigh Thomson, 2006
Funded by: Arthritis Foundation of Australia |
| The protective effect of G82S RAGE on cardiovascular events in rheumatoid arthritis, 2006 - 2007
Funded by: Australian Rotary Health Research Fund |
| Interleukin 1 and Tolerance in Type 1 Diabetes, 2006 - 2009
Funded by: Juvenile Diabetes Foundation - International |
| Receptor for Advanced Glycation End products and cardiovascular disease risk in subjects with Rheumatoid Arthritis, 2005 - 2005
Funded by: Australian Rotary Health Research Fund |
| Immunological therapies for cancer and autoimmunity, 2005 - 2009
Funded by: National Health and Medical Research Council |
| Pre Clinical Studies of Antigen Specific Dendritic Cell Immunotherapy For type 1 Diabetes in NOD Mice, 2003 - 2004
Funded by: Juvenile Diabetes Foundation - International |
| PAHF block funding, 2003 - 2004
Funded by: Princess Alexandra Hospital Auxiliary |
| Dentritic cell function, migration and modulation in a murine model of inflammatory arthritis., 2002 - 2002
Funded by: Princess Alexandra Hospital Auxiliary |
| Induction of antigen-specific tolerance through inhibition of RelB function in dendtritic cells, 2002 - 2004
Funded by: National Health and Medical Research Council |
| Regulation And function Of The Transcription Factor RelB In Human Dendritic Cells, 2001 - 2001
Funded by: Princess Alexandra Hospital Auxiliary |
| Role of TNFa In Dendritic Cell Migration In A Mouse Model Of Arthritis, 2001 - 2001
Funded by: Arthritis Foundation of Australia |
| Set up 2 collaborations for genomic screening of cDNA derived from initial serial arthroscopic synovial tissue biopsies., 2001 - 2001
Funded by: University of Queensland |
| Dendritic cell function, migration and modulation in a murine model of inflammatory arthritis, 2000 - 2000
Funded by: Princess Alexandra Hospital Auxiliary |
| Dendritic cell function, migration and modulation in a murine model of inflammatory arthritis, 2000 - 2000
Funded by: National Health and Medical Research Council |
| The role of TAP and MHC class I expression in the response to melanoma immunotherapy using autologous dendritic cells, 2000 - 2000
Funded by: Princess Alexandra Hospital Auxiliary |
| The role of TAP and MHC class I expression in the response to melanoma immunotherapy using autologous dendritic cells, 2000 - 2002
Funded by: National Health and Medical Research Council |
| A phase II clinical trial in patients with metastatic melanoma comparing autologous dendritic cells pulsed with autologous tumour peptides and melanoma associated peptides linked to the endoplasmic re, 1999 - 2000
Funded by: Queensland Cancer Fund |
| Identification and characterisation of CC Chemokine receptor-expressing T cells in rheumatoid arthritis, 1999 - 1999
Funded by: Arthritis Foundation of Australia |
| Regulation and Function of the Transcription Factor RelB in Human Dendritic Cells, 1999 - 2001
Funded by: National Health and Medical Research Council |
| The role of TAP and MHC Class I expression in the response to melanoma immunotherapy, 1999 - 1999
Funded by: Princess Alexandra Hospital Auxiliary |
| A Phase I/II Clinical Trial to Test Tumour Vaccines Comprising with Protein or Autologous Tumour Antigen Autologous Dandritic Cells Generated in a Closed Bag System Pulsed, 1998 - 1998
Funded by: Mayne Bequest Fund |
| Analysis of activated T cells from rheumatoid joints, 1998 - 1998
Funded by: Arthritis Foundation of Australia |
| Page: | 1 2  |
| |
| Select all records |
| |
